Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes

Recruiting

Phase 1

Phase 2

Adjunctive TherapyCombination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes

Sponsor:

UCLA

Code:

NCT05696366

Conditions

Type 1 Diabetes

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Sotagliflozin

Volagidemab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by University of California, San Diego on 2024-11-04.